US DMFs Filed
USA (Orange Book)
PharmaCompass offers a list of Ramipril API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ramipril manufacturer or Ramipril supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ramipril manufacturer or Ramipril supplier.
PharmaCompass also assists you with knowing the Ramipril API Price utilized in the formulation of products. Ramipril API Price is not always fixed or binding as the Ramipril Price is obtained through a variety of data sources. The Ramipril Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ramipril manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ramipril, including repackagers and relabelers. The FDA regulates Ramipril manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ramipril API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
CLICK HERE to find a list of Ramipril manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ramipril supplier is an individual or a company that provides Ramipril active pharmaceutical ingredient (API) or Ramipril finished formulations upon request. The Ramipril suppliers may include Ramipril API manufacturers, exporters, distributors and traders.
CLICK HERE to find a list of Ramipril suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ramipril DMF (Drug Master File) is a document detailing the whole manufacturing process of Ramipril active pharmaceutical ingredient (API) in detail. Different forms of Ramipril DMFs exist exist since differing nations have different regulations, such as Ramipril USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ramipril DMF submitted to regulatory agencies in the US is known as a USDMF. Ramipril USDMF includes data on Ramipril's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ramipril USDMF is kept confidential to protect the manufacturer’s intellectual property.
CLICK HERE to find a list of Ramipril suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ramipril Drug Master File in Korea (Ramipril KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ramipril. The MFDS reviews the Ramipril KDMF as part of the drug registration process and uses the information provided in the Ramipril KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ramipril KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ramipril API can apply through the Korea Drug Master File (KDMF).
CLICK HERE to find a list of Ramipril suppliers with KDMF on PharmaCompass.
A Ramipril CEP of the European Pharmacopoeia monograph is often referred to as a Ramipril Certificate of Suitability (COS). The purpose of a Ramipril CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ramipril EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ramipril to their clients by showing that a Ramipril CEP has been issued for it. The manufacturer submits a Ramipril CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ramipril CEP holder for the record. Additionally, the data presented in the Ramipril CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ramipril DMF.
A Ramipril CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ramipril CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
CLICK HERE to find a list of Ramipril suppliers with CEP (COS) on PharmaCompass.
A Ramipril written confirmation (Ramipril WC) is an official document issued by a regulatory agency to a Ramipril manufacturer, verifying that the manufacturing facility of a Ramipril active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ramipril APIs or Ramipril finished pharmaceutical products to another nation, regulatory agencies frequently require a Ramipril WC (written confirmation) as part of the regulatory process.
CLICK HERE to find a list of Ramipril suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ramipril as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ramipril API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ramipril as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ramipril and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ramipril NDC to their finished compounded human drug products, they may choose to do so.
CLICK HERE to find a list of Ramipril suppliers with NDC on PharmaCompass.
Ramipril Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ramipril GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ramipril GMP manufacturer or Ramipril GMP API supplier for your needs.
A Ramipril CoA (Certificate of Analysis) is a formal document that attests to Ramipril's compliance with Ramipril specifications and serves as a tool for batch-level quality control.
Ramipril CoA mostly includes findings from lab analyses of a specific batch. For each Ramipril CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ramipril may be tested according to a variety of international standards, such as European Pharmacopoeia (Ramipril EP), Ramipril JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ramipril USP).